56. Behcet disease Clinical trials / Disease details


Clinical trials : 81 Drugs : 107 - (DrugBank : 30) / Drug target genes : 36 - Drug target pathways : 116

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1ChiCTR2000031637
2020-04-101990-01-01Behcet’s Uveitis Therapy (BUT) StudyBehcet’s Uveitis Therapy (BUT) Study Uveitis in Behcet’s DiseaseArm A: Interferon Alpha-2a;Arm B:Adalimumab;Arm C:Cyclosporine;The First Affiliated Hospital of Chongqing Medical UniversityNULLPendingBothArm A:90;Arm B:90;Arm C:90;Phase 4China
2NCT03209219
(ClinicalTrials.gov)
June 30, 20174/7/2017Interferon a2a Versus Cyclosporine for Refractory Behçet's Disease UveitisRandomized Prospective Comparative Study of Interferon a2a and Cyclosporine in Patients With Refractory Behçet's Disease UveitisBehçet Disease;UveitisDrug: Interferon Alfa-2A;Drug: Cyclosporine PillPeking Union Medical College HospitalNULLCompleted18 Years65 YearsAll28Phase 3China